NCT00289757View on ClinicalTrials.gov

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule

PHASE4CompletedINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

January 1, 2004

Primary Completion Date

March 1, 2013

Study Completion Date

March 1, 2013

Conditions

Hepatitis A

Interventions

BIOLOGICAL

Havrix™

2 doses at 6 months interval

Trial Locations (1)

2610

GSK Investigational Site, Wilrijk

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY